Order Article Reprints

Novak J, Salgia R, West H, Villalona-Calero MA, Sampath S, Williams T, Villaflor V, Massarelli E, Pathak R, Koczywas M, et al. Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC. Cancers. 2022; 14(16):3983. https://doi.org/10.3390/cancers14163983

Novak, Jennifer, Ravi Salgia, Howard West, Miguel A Villalona-Calero, Sagus Sampath, Terence Williams, Victoria Villaflor, Erminia Massarelli, Ranjan Pathak, Marianna Koczywas, and et al. 2022. "Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC" Cancers 14, no. 16: 3983. https://doi.org/10.3390/cancers14163983

Novak, J., Salgia, R., West, H., Villalona-Calero, M. A., Sampath, S., Williams, T., Villaflor, V., Massarelli, E., Pathak, R., Koczywas, M., Chau, B., & Amini, A. (2022). Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC. Cancers, 14(16), 3983. https://doi.org/10.3390/cancers14163983